Page last updated: 2024-10-23

aztreonam and Uterine Diseases

aztreonam has been researched along with Uterine Diseases in 2 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Uterine Diseases: Pathological processes involving any part of the UTERUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sengoku, K1
Shimizu, T1
Haga, H1
Inoue, R1
Yamazaki, T1
Mizoguchi, H1
Torii, Y1
Sagawa, T1
Saitou, S1
Hatase, T1
Katabuchi, H1
Watanabe, H1
Umezu, J1
Yakushiji, M1
Kato, T1

Other Studies

2 other studies available for aztreonam and Uterine Diseases

ArticleYear
[Pharmacokinetic and clinical studies on aztreonam in perinatal period].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4

    Topics: Adult; Amniotic Fluid; Aztreonam; Bacterial Infections; Chorioamnionitis; Female; Fetal Blood; Genit

1990
[Clinical studies on aztreonam in infections in obstetrics and gynecology].
    The Japanese journal of antibiotics, 1985, Volume: 38, Issue:12

    Topics: Adult; Aged; Aztreonam; Bacterial Infections; Drug Evaluation; Female; Humans; Infusions, Parenteral

1985